Variant report
Variant | esv3434598 |
---|---|
Chromosome Location | chr3:89858062-89861960 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:89858428..89860418-chr3:89862912..89865718,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs545049014 | chr3:89858098-89858099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs563334091 | chr3:89858137-89858138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs11719091 | chr3:89858157-89858158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs76680207 | chr3:89858163-89858164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs542491900 | chr3:89858201-89858202 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs76289597 | chr3:89858220-89858221 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs111951051 | chr3:89858226-89858227 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs528248710 | chr3:89858254-89858255 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs377705595 | chr3:89858276-89858277 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571366352 | chr3:89858283-89858284 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs79617218 | chr3:89858299-89858300 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs80006158 | chr3:89858325-89858326 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs144900045 | chr3:89858364-89858365 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs142015951 | chr3:89858407-89858408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555988992 | chr3:89858473-89858474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs79745690 | chr3:89858501-89858502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs567775486 | chr3:89858545-89858546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs535176020 | chr3:89858587-89858588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs138471156 | chr3:89858639-89858640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs556071593 | chr3:89858661-89858662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs577758106 | chr3:89858664-89858665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs542041771 | chr3:89858690-89858691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs114949521 | chr3:89858694-89858695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs142587853 | chr3:89858696-89858697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs575207002 | chr3:89858699-89858700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs530856085 | chr3:89858763-89858764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184085973 | chr3:89858777-89858778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs114798886 | chr3:89858778-89858779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs540461056 | chr3:89858784-89858785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs564914383 | chr3:89858804-89858805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs187868899 | chr3:89858809-89858810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs552020980 | chr3:89858812-89858813 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs550664775 | chr3:89858826-89858827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs115573791 | chr3:89858835-89858836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs529676399 | chr3:89858836-89858837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs549418783 | chr3:89858856-89858857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs142836134 | chr3:89858865-89858866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs1915731 | chr3:89858877-89858878 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs528424745 | chr3:89858892-89858893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs547206946 | chr3:89858894-89858895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs571487985 | chr3:89858913-89858914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs546584348 | chr3:89858943-89858944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs551353768 | chr3:89858991-89858992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs367594303 | chr3:89858992-89858993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs557001426 | chr3:89858994-89858995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs143383105 | chr3:89859027-89859028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs545881826 | chr3:89859040-89859041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs192202325 | chr3:89859052-89859053 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs573125588 | chr3:89859083-89859084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs141643967 | chr3:89859090-89859091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 19547694 | CNVD |
Cancer | 20164919 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:89853200-89858200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr3:89858000-89858400 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
3 | chr3:89858200-89859000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr3:89858400-89859000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
5 | chr3:89859000-89861600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr3:89860400-89867000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr3:89860800-89861200 | ZNF genes & repeats | Pancreas | Pancrea |
8 | chr3:89861600-89861800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |